We are a leading pharmaceutical market access company focused on niche therapeutics for Rare Diseases and Specialty Care. We provide fast and sustainable market access solutions into the MENAT (Middle East, North Africa and Turkey) region to our strategic partners. We act as the exclusive regional commercial partners for some of the leading global pharmaceutical companies. We generate strategic plans and advise on go to market strategies for organizations assessing their entry into the MENAT Region.
Founded in 2012, we have grown and established a footprint in more than 12 countries across the MENAT region.
We have consciously built our organization to tackle the obstacles in access for innovative treatments for our rare disease community.
We connect innovative global biotech companies with local healthcare providers, to reach the right patient at the right time. We address the needs of our principals through our collaborative models. We provide unprecedented flexibility to meet the requirements of each product through specific strategies in regulatory and access pathways, medical and marketing support, and much more.
Looking to learn some more about Genpharm? Download our Corporate Profile to know more about what we do, how we do it, and why we do it.
Download